Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

MACK Merrimack Pharmaceuticals Inc

15,1575

0,00 (0,00%)

31 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals

Merrimack Pharmaceuticals (NASDAQ:MACK)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Merrimack Pharmaceuticals Charts.

Merrimack Pharmaceuticals (NASDAQ:MACK)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Merrimack Pharmaceuticals Charts.

News Merrimack Pharmaceuticals Inc

Form 15-12G - Securities registration termination [Section 12(g)]
Montag 20 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
Freitag 10 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 10 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
Freitag 10 Mai 2024 (3 Wochen vor) • Business Wire

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Donnerstag 9 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 9 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution
Donnerstag 9 Mai 2024 (3 Wochen vor) • Business Wire

Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution
Dienstag 30 April 2024 (1 Monat vor) • Business Wire

Merrimack Receives $225 Million Milestone Payment from Ipsen
Mittwoch 27 März 2024 (2 Monate vor) • Business Wire

Form 425 - Prospectuses and communications, business combinations
Donnerstag 7 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Merrimack Reports Full Year 2023 Financial Results
Donnerstag 7 März 2024 (3 Monate vor) • Business Wire

Weitere Merrimack Pharmaceuticals Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen